Infection and Immunity, October 2000, p. 5581-5586, Vol. 68, No. 10
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Amplifies the
Effects of Partially Purified Pasteurella haemolytica
Leukotoxin on Bovine Neutrophils in a
2-Integrin-Dependent Manner
Department of Pathobiological Sciences, University of Wisconsin School of Veterinary Medicine, Madison, Wisconsin,1 and National Animal Disease Center, USDA Agricultural Research Service, Ames, Iowa2
Received 10 April 2000/Returned for modification 27 May 2000/Accepted 4 July 2000
| |
ABSTRACT |
|---|
|
|
|---|
The influx and death of polymorphonuclear leukocytes within the
infected lung are hallmarks of bovine pasteurellosis. Recent reports
have shown that the Pasteurella haemolytica leukotoxin (LKT) and other RTX toxins bind
2-integrins on target
cells. In this study we demonstrate that exposure of bovine neutrophils to recombinant bovine interleukin-1
upregulates
2-integrins (CD11a/CD18), which in turn enhance the
binding and amplify the biological effects of partially purified LKT on
these cells. LKT binding and cytotoxicity were inhibited by addition of
an anti-integrin antibody (CD11a/CD18). These findings help to clarify
the early events that occur in bovine pasteurellosis and support the
hypothesis that inflammatory mediators might increase the severity of
pasteurellosis by causing upregulation of
2-integrins
that serve as an LKT receptor on bovine neutrophils.
| |
INTRODUCTION |
|---|
|
|
|---|
Bovine pneumonic pasteurellosis is
an acute fibrinonecrotizing pleuropneumonia characterized by an influx
of neutrophils into the alveoli and interlobular septa of the lung
(1, 25, 39). Some of these infiltrating leukocytes undergo
apoptosis in the lung during the infection (17). In severe
cases the inflammation extends onto the pleural surface (25,
39). Although Pasteurella haemolytica produces several
virulence factors that play a role in the pathogenesis of
pasteurellosis, the most important is thought to be a leukotoxin (LKT),
whose effects are specific for ruminant leukocytes and platelets
(3, 13, 27, 28). The P. haemolytica LKT is a
member of a large family of exotoxins produced by gram-negative bacteria, known as RTX toxins, that share similar synthesis and secretion systems and exhibit related biological activities
(37). Previously, it has been shown that other RTX toxins
bind to
2-integrins on target cells (16).
More recently, anti-
2-integrin monoclonal antibodies
(MAbs) have been shown to inhibit the cytolysis by P. haemolytica LKT of BL-3 cells (a bovine B lymphoblastoid cell line) and peripheral blood neutrophils (2, 14, 18).
Anti-
2-integrin MAbs have also been shown to block
binding of LKT to blotted lysates of BL-3 cells and neutrophils
(14, 18). The mechanism by which the RTX toxins exert their
lethal effect on target cells is only partially understood but is
thought to involve changes in selective permeability of the cytoplasmic
membrane that result in Ca2+ influx and ATP efflux
(23, 34, 36, 37).
The proinflammatory cytokine interleukin-1
(IL-1
), which is
produced by alveolar macrophages and other cells, can stimulate migration and functional activation of polymorphonuclear leukocytes (PMNs) in the lung (10). The
2-integrins,
which are found on most circulating leukocytes, play an important role
in the extravasation of leukocytes during the inflammatory response
(11). Studies of other inflammatory stimuli have shown that
they can increase surface expression and avidity of
2-integrins on neutrophils (24, 38). In this
study, we demonstrate an increase in
2-integrin expression on bovine PMNs following their in vitro incubation with
IL-1
. This in turn enhanced the binding and cytotoxicity of
partially purified LKT for the PMNs. This effect was diminished by
addition of an anti-
2-integrin antibody (CD11a/CD18).
These findings suggest that the ability of IL-1
to upregulate
2-integrins could increase their opportunity to act as a
receptor for LKT on bovine PMNs and by so doing increase the severity
of bovine pasteurellosis.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Leukocyte preparation. Leukocyte separation was performed as described previously (6). Briefly, peripheral blood was collected from healthy Holstein donor cows using Vacutainer tubes (Becton-Dickinson, Rutherford, N.J.) that contained sodium citrate (0.38% final volume) as an anticoagulant. The blood was centrifuged (250 × g for 20 min), and the platelet-rich plasma was removed. Neutrophils were obtained from the remaining blood by rapid hypotonic lysis and centrifugation through a Percoll gradient (Pharmacia, Uppsala, Sweden), as described previously (6). The neutrophil pellets were washed twice in Hanks' balanced salt solution (HBSS) and resuspended at 107 cells/ml in HBSS supplemented with 5% fetal bovine serum. These cell suspensions were greater than 95% neutrophils, as determined by evaluation of Diff-Quick-stained cytocentrifuge smears, and greater than 95% viable, as estimated by trypan blue dye exclusion.
IL-1
treatment.
Bovine PMNs (1 × 106 to
2 × 106 per ml in HBSS with 5% fetal bovine serum)
were incubated with 50 ng of recombinant bovine IL-1
(generously
provided by D. Shuster, American Cyanamid Company, Princeton, N.J.) at
37°C for 15 min. We have previously reported that this treatment
stimulates the oxidative burst, degranulation, and adhesiveness of
bovine neutrophils (26). Following this period of
incubation, the cells were washed with HBSS and incubated with LKT,
MAbs, or RGD peptide, as described for the various experiments.
P. haemolytica. Two strains of P. haemolytica A1 were used in this study. The first of these (D153) was a wild-type strain isolated from a pneumonic bovine lung. The second was an isogenic gene replacement mutant of D153. This mutant, which has a deletion in frame in lktA (corresponding to amino acids 34 through 378), has a rate of growth and production of other known virulence determinants that are unaltered compared with those of the parent strain (unpublished observations).
LKT production and partial purification.
All LKT
preparations were produced and partially purified as described
previously (6). Briefly, P. haemolytica A1 was
inoculated onto blood agar (Remel, Lenexa, Kans.) and incubated
overnight at 37°C. The bacteria were washed from the agar surface
with 10 ml of brain heart infusion broth containing 0.5% yeast extract (Difco, Detroit, Mich.) and incubated at 37°C for 1 h while
rotating (8 rpm) in 15-ml polypropylene tubes. A 10-ml aliquot of this suspension was then used to inoculate 200 ml of brain heart infusion broth-0.5% yeast extract in a 500-ml flask, which was incubated for
2 h at 37°C with shaking (120 rpm). The bacteria were collected by centrifugation (1,600 × g for 15 min), resuspended
in 200 ml of RPMI 1640 supplemented with L-glutamine (4.0 mM), and incubated on a shaker apparatus (at 120 rpm) for 4 h at
37°C. The bacteria were pelleted by centrifugation (1,600 × g for 20 min), and the crude LKT-containing supernatant was
collected and passed through a 0.45-mm-pore-size bottletop filter
(Nalgene, Rochester, N.Y.) to remove any residual bacteria. Aliquots of
crude LKT were concentrated with an Amicon ultrafiltration unit
equipped with a 62-mm-diameter XM-50 ultrafiltration membrane. The
volume was then reduced to 10 to 20 ml over a 1- to 2-h period by
applying a transmembrane pressure of 60 lb/in2 with
nitrogen gas. The partially purified LKT preparation that remained was
then collected and stored as 5-ml aliquots at
70°C. One unit of LKT
activity was defined as the dilution causing 50% killing of bovine
peripheral blood leukocytes when incubated at 37°C for 1 h, as
determined by trypan blue exclusion. Partially purified LKT was stored
at
70°C until used in an experiment.
Biotinylation of LKT. Biotinylated LKT was prepared as described previously (6). Briefly, an 80:1 molar ratio of NHS-LC-biotin (Pierce Chemical, Rockford, Ill.) to partially purified LKT was incubated in an ice bath for 20 min. The mixture was then concentrated to 1 ml in a prechilled Amicon centricon tube (50-kDa cutoff). The reaction was stopped by the addition of crystalline bovine serum albumin (30 mg) and incubated at 4°C for 30 min. Unbound biotin was eliminated by buffer exchange over a Sephadex G-25 column (1 by 25 cm), using phosphate-buffered saline (pH 7.2) as the elution buffer. The LKT eluted in the void volume in 7 to 8 min, as monitored by absorbance at 280 nm. LKT activity was assessed by incubating biotinylated LKT with bovine peripheral leukocytes for 30 min at 37°C, followed by trypan blue exclusion.
MAbs. A commercial murine immunoglobulin G (IgG) MAb specific for bovine LFA-1 (BAT75A) was purchased as ascites fluid from VMRD (Pullman, Wash.). Although some have described this MAb as specific for CD18 (15), its specificity (CD18 or CD11a) has not been precisely defined (W. C. Davis, personal communication). A murine IgG1 MAb (CA1.4E9) that is specific for canine CD18 and cross-reacts with bovine CD18 was purchased as ascites from Serotec (United Kingdom). For indirect staining of cells, an Fc-specific fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG (Sigma, St. Louis, Mo.) was used. Briefly, the PMNs (106 cells) were centrifuged and resuspended in 50 µl of HBSS. The appropriate MAb was added (50-µg/ml final concentration in 50 µl of HBSS), and the cells were incubated at 4°C for 45 min. The FITC-conjugated anti-mouse IgG was then added (1:100 dilution), and the cells were incubated at 4°C for an additional 30 min. Following this, the cells were washed twice with HBSS and assessed by flow cytometry.
Detection of LKT binding. Flow cytometric analysis of LKT binding to intact PMNs was performed as described previously (6). Briefly, bovine PMNs (106) were incubated with biotinylated LKT (10 to 20 U) for 10 min at 4°C. The cells were washed and resuspended in HBSS. Extra-avidin-FITC (Sigma) was added (in a volume of 4 µl), and the cells were incubated for 30 min at 4°C. The cells were then washed with HBSS, resuspended in 0.3 ml of HBSS, and fixed with 0.4% paraformaldehyde (final concentration). Cells were analyzed by flow cytometry using a Coulter Profile II flow cytometer (10,000 to 30,000 cells were scored for green fluorescence on a log scale).
In some experiments the role of
2-integrins in LKT
binding was evaluated using the anti-
2-integrin
described above or an RGD peptide (Sigma). The MAbs or RGD peptides (1 mM final concentration) were added to bovine PMNs (106) and
incubated at 37°C for 15 min. After incubation, the cells were washed
and the biotinylated LKT was added. The cells were then prepared for
flow cytometric analysis of LKT binding as described above. An RGES
peptide (Arg-Gly-Glu-Ser) (Sigma) that does not bind to
2-integrins (20) was used as a negative control.
Cytotoxicity assay.
2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium
hydroxide (XTT) was used to evaluate LKT cytotoxicity for bovine PMNs,
as previously described (32). Briefly, bovine PMNs
(106) were incubated with partially purified LKT (1 to 5 U)
for 1 h at 37°C on a rotating platform. The cells were plated
into triplicate wells in a 96-well microplate and incubated at 37°C
for 1 h. XTT (1 mg/ml) was added (50 µl/well) and incubated at
37°C for 1 h. Absorbance was determined using a microplate
reader (MR 600; Dynatech). The percent cytotoxicity was calculated as
[1
(optical density of toxin-incubated cells/optical density
of toxin-free cells)] × 100.
Statistical analysis. Data were analyzed for statistical significance using a repeated-measures analysis of variance, performed by the Instat software program (GraphPad, San Diego, Calif.). The flow cytometry data were analyzed using the WInMDI version 2.8 software.
| |
RESULTS |
|---|
|
|
|---|
Recombinant bovine IL-1
upregulates
2-integrins
on bovine PMNs.
We first examined the expression of
2-integrins on IL-1
-stimulated bovine PMNs by flow
cytometry, using two MAbs that bind bovine
2-integrins
(BAT75A and CA1.4E9). We observed a significant increase in expression
of
2-integrins on bovine PMNs that had been incubated
with 50 ng of recombinant bovine IL-1
for 15 min at 37°C (Fig.
1). Similar results were obtained with
both MAbs (2.6- and 2.9-fold increases in the number of positive cells
using MAbs BAT75A and CA1.4E9, respectively). To the best of our
knowledge, this is the first report of enhanced expression of
2-integrins on IL-1-treated bovine neutrophils.
|
Preincubation of bovine PMNs with IL-1
enhances binding of
partially purified LKT.
IL-1
-treated and control PMNs were
incubated with biotinylated LKT for 10 min at 4°C, as described in
Materials and Methods. The cells were then incubated with
Extra-avidin-FITC and analyzed by flow cytometry. As shown in Fig.
2, the IL-1
-treated PMNs exhibited a
66% increase in the number of LKT-positive cells compared with control
PMNs. A low level of LKT binding was observed when we used a similarly
prepared culture filtrate from a P. haemolytica lktA mutant
that produces an incomplete LKT that lacks cytolytic activity (Fig. 2).
This observation speaks against the likelihood that our assay simply
detected binding of lipopolysaccharide (LPS) in the LKT preparations.
LKT binding also was not enhanced when the PMNs were preincubated with
heat-inactivated IL-1
(100°C for 10 min) (Fig. 2). The binding of
LKT to both IL-1
-stimulated and control PMNs was significantly
reduced (76 and 68%, respectively) when the PMNs were incubated with
anti-
2-integrin MAb BAT75 before exposure to
biotinylated LKT. However, inhibition of LKT binding was not observed
when we used MAb CA1.4E9, despite its ability to bind to
IL-1-stimulated PMNs (Fig. 1B). We also used an RGD peptide that is
known to inhibit integrin binding (20) as another measure of
the role of
-integrins in LKT binding to PMNs. Although the RGD
peptide (1 mM) inhibited LKT binding to control PMNs by 59%, it did
not inhibit LKT binding to IL-1
-stimulated PMNs (Fig. 3). As expected, a negative control
peptide (RGES) did not inhibit LKT binding to either control or
IL-1-stimulated bovine PMNs.
|
|
Preincubation with recombinant bovine IL-1
enhances the
cytotoxicity of partially purified LKT for bovine PMNs.
We
previously demonstrated that biotinylated LKT retains its cytotoxicity
for bovine PMNs and that its binding to and cytotoxicity for bovine
PMNs can be blocked by an anti-LKT MAb (MM601) (6). In the
present study we observed an 85% increase in LKT-mediated cytotoxicity
by PMNs stimulated with IL-1
compared with control PMNs (Fig.
4). LKT-mediated cytotoxicity was reduced
by 81 and 72%, respectively, when IL-1
-stimulated and control PMNs
were incubated with the anti-
2-integrin MAb BAT75A
before addition of LKT. Incubation with MAb CA1.4E9 did not reduce
LKT-mediated cytotoxicity for either IL-1
-stimulated or control PMNs
(data not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
The potential adverse effect of PMNs in the pathogenesis of pneumonic pasteurellosis was demonstrated previously by investigators, who found that depletion of peripheral blood neutrophils reduced the severity of lung damage in cows with experimental pasteurellosis (4, 30). Although the virulence determinants of P. haemolytica are incompletely understood, it is well accepted that the P. haemolytica LKT has an array of biological effects on ruminant PMNs. At low concentrations the LKT stimulates a respiratory burst, degranulation, release of eicosanoids, and secretion of cytokines (7, 9, 12, 19). Exposure of PMNs to LKT for a longer time period, or to higher LKT concentrations, results in cell death by apoptosis or necrosis (33, 34).
The responses of PMNs to inflammation are dependent on both the
stimulus and the extracellular environment.
2-Integrins
are important for PMN responses to infection and injury (8, 10, 15, 31, 38). In resting PMNs, integrins are maintained in a
conformationally inactive state, in which they are unable to bind their
respective ligands (24, 38). Activation of PMNs induces an
upregulation of integrins on the cell surface and conformational changes that increase avidity for their respective ligands (4, 25). The proinflammatory cytokine IL-1
is one stimulus that can activate
2-integrins on PMNs in vivo
(29), and it is responsible in part for the migration of
PMNs into the lung (10, 11).
In the present study, we demonstrate that incubation of bovine PMNs
with recombinant bovine IL-1
increased their binding and
susceptibility to the cytotoxic effects of P. haemolytica LKT. Several lines of evidence suggest that the increased binding and
susceptibility were mediated by
2-integrins. First, we
observed an upregulation of
2-integrins on the cell
surface after IL-1 stimulation, as detected by flow cytometry using two
different anti-integrin MAbs. To the best of our knowledge, this is the first report of the upregulation of
2-integrins on
IL-1-stimulated bovine neutrophils. Unpublished data from a different
laboratory demonstrated a similar increase in CD18 expression on
IL-1-stimulated bovine PMNs (M. Kehrli, personal communication).
Second, the binding of partially purified LKT was inhibited by addition
of an anti-LFA-1 MAb (BAT75A). Third, the LKT-mediated killing of
IL-1
-activated and control PMNs was inhibited by preincubation with
the BAT75A MAb. This last finding is contrary to that previously
reported by Ambagala et al. (2), who did not observe
inhibition of LKT-mediated killing of bovine PMNs by BAT75A
in vitro. However, a larger amount of LKT was used in the prior
study, which could explain the difference between their results and ours.
In the present study, we observed variability in the ability of
anti-
2-integrin MAbs and RGD peptides to inhibit LKT
binding to and cytotoxicity for bovine PMNs. However, these
observations are similar to those of other investigators, who observed
that cytotoxicity was influenced by the amount of LKT present, the cell
type being used, and the MAb being added (2, 14, 18, 36).
Our results are consistent with the pattern reported by other
investigators who observed a diminution, but not complete inhibition,
of LKT binding and cytotoxicity by anti-
2-integrin MAbs (2, 14,
18, 36). Our work is complementary to the recent report of
Jayaseelan et al. (14) demonstrating diminished binding of
LKT to lysates of PMNs obtained from
2-integrin-deficient calves. In that study, PMNs from
2-integrin-deficient calves were also partially
resistant to the cytotoxicity of LKT (14). The present study
provides additional evidence for the importance of
2-integrins in LKT binding. Exposure of neutrophils to a
stimulus that upregulates
2-integrins (IL-1
)
increases LKT binding and cytotoxicity for bovine PMNs. This is not a
trivial observation, because numerous inflammatory mediators will be
present in the lung during pasteurellosis. The ability of these
mediators to enhance the susceptibility of bovine PMNs to P. haemolytica LKT could be an important early determinant
influencing the severity of pulmonary pasteurellosis.
There are several limitations to our study. First, we used a partially
purified LKT preparation that does contain LPS (6). However,
we have shown previously that binding of this partially purified LKT to
bovine PMNs is inhibited by an anti-LKT MAb (6). Likewise,
in the present study we detected a low level of binding of a
noncytolytic mutant LKT preparation to bovine neutrophils. This mutant
LKT has been found by other investigators to bind to membrane-bound
bovine leukocyte lysates but to elicit a very weak influx of
extracellular Ca2+ (S. Maheswaran, personal communication).
This suggests that it has limited ability to bind or activate intact
bovine leukocytes. These observations suggest that contaminating
endotoxin is not the major component recognized by our LKT binding
assay. Although our flow cytometry assay might be somewhat less
sensitive than the cell lysate LKT binding methods described by other
investigators, our technique has the distinct advantage of using intact
cells. This avoids the possibility that the blotted
2-integrins in the cell lysates contain exposed epitopes
that would not be accessible to LKT on intact cells. Furthermore, it is
only by using intact cells that one can begin to examine regulatory
events that alter
2-integrin expression and LKT binding.
Finally, one might consider the biological relevance of the
observations that were made in this study. It is well known that infection with bovine herpes virus type 1, or other respiratory viruses, can greatly enhance the susceptibility of cattle to P. haemolytica pneumonia (22, 25). The mechanism for this
enhanced susceptibility has eluded investigators. We propose that one
possibility is that inflammatory cytokines (i.e., IL-1 and others) that
are released during viral infection could enhance the expression of
2-integrins on bovine leukocytes (22). When
P. haemolytica then entered the lung, it would encounter
leukocytes whose
2-integrins were primed for enhanced
binding, and perhaps a biological response, to its LKT. This could
trigger the release of additional cytokines, and other inflammatory
mediators, in response to LKT (7, 9, 12, 19). This cascade
of mediators could then amplify pulmonary inflammation, resulting in
the severe fibrinous pneumonia that exemplifies the most severe
manifestation of pasteurellosis. In keeping with this possibility, we
have obtained preliminary evidence that other inflammatory stimuli
(i.e., tumor necrosis factor alpha, LPS, and P. haemolytica
LKT itself) also enhance LKT binding to and cytotoxicity for bovine
PMNs (unpublished observations). These observations are consistent with
previous reports that P. haemolytica LKT and LPS stimulate
release of inflammatory cytokines, including IL-1, both in vitro and in
vivo (21, 32, 40, 41). Thus, once pasteurellosis is
established in the lung, the presence of LKT and LPS would stimulate
continued release of IL-1 and other inflammatory mediators that would
sustain
2-integrin expression and exacerbate pulmonary
inflammation (5, 7, 9, 19, 32, 41). It is also worth noting
that stimulation of LFA-1 (the putative LKT receptor) on human
neutrophils is reported to enhance apoptosis in vitro (35).
It is tempting to speculate that binding of LKT to LFA-1 on bovine
neutrophils might be responsible in part for the apoptosis that LKT has
been reported to cause (9, 33, 34).
In summary, the results of this study provide evidence that exposure of
bovine neutrophils to IL-1
upregulates
2-integrins, which in turn enhance the binding and cytotoxicity of partially purified LKT. If similar events occur in vivo, it might explain in part
the intense inflammation that exemplifies bovine pasteurellosis (25). These observations are also consistent with previous
reports that neutrophil depletion in cattle can prevent some of the
adverse events associated with P. haemolytica infection in
the bovine lung (4, 30).
| |
ACKNOWLEDGMENTS |
|---|
We thank Steve Giles for assistance in preparation of the illustrations.
This work was supported by funds from the Wisconsin Agricultural
Experiment Station, the University of Wisconsin
Madison Industrial and
Economic Development Research Program, and the University of Wisconsin
School of Veterinary Medicine. F. Leite was supported by
CAPES-Ministerio da EducaÇão, Brazil.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Pathobiological Sciences, School of Veterinary Medicine, 2015 Linden Drive West, Madison, WI 53706. Phone: (608) 262-8102. Fax: (608) 262-8102. E-mail: czuprync{at}svm.vetmed.wisc.edu.
Editor: W. A. Petri Jr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ackermann, M. R.,
K. A. Brogden,
A. F. Florance, and M. E. Kehrli.
1999.
Induction of CD18-mediated passage of neutrophils by Pasteurella haemolytica in pulmonary bronchi and bronchioles.
Infect. Immun.
67:659-663 |
| 2. | Ambagala, T. C., A. P. N. Ambagala, and S. Srikumaran. 1999. The leukotoxin of Pasteurella haemolytica binds to integrins on bovine leukocytes. FEMS Microbiol. Lett. 179:161-167[Medline]. |
| 3. | Baluyut, C. S., R. R. Simonson, W. J. Bemrick, and S. K. Maheswaran. 1981. Interaction of Pasteurella haemolytica with bovine neutrophils: identification and partial characterization of a cytotoxin. Am. J. Vet. Res. 42:1920-1926[Medline]. |
| 4. | Breider, M. A., R. D. Walker, F. M. Hopkins, T. W. Shultz, and T. L. Bowersock. 1988. Pulmonary lesions induced by Pasteurella haemolytica in neutrophil sufficient and neutrophil deficient calves. Can. J. Vet. Res. 52:205-209[Medline]. |
| 5. | Breider, M. A., and Z. Yang. 1994. Tissue factor expression in bovine endothelial cells induced by Pasteurella haemolytica lipopolysaccharide and interleukin-1. Vet. Pathol. 31:55-60[Abstract]. |
| 6. | Brown, F. J., F. Leite, and C. J. Czuprynski. 1997. Binding of Pasteurella haemolytica leukotoxin to bovine leukocytes. Infect. Immun. 65:3719-3724[Abstract]. |
| 7. | Clinkenbeard, K. D., C. R. Clarke, C. M. Hague, P. Clinkenbeard, S. Srikumaran, and R. J. Morton. 1994. Pasteurella haemolytica leukotoxin-induced synthesis of eicosanoids by bovine neutrophils in vitro. J. Leukoc. Biol. 56:644-649[Abstract]. |
| 8. | Cronstein, B. N., and G. Weissmann. 1993. The adhesion molecules of inflammation. Arthritis Rheum. 36:147-157[Medline]. |
| 9. |
Czuprynski, C. J.,
E. J. Noel,
O. Ortiz-Carranza, and S. Srikumaran.
1991.
Activation of bovine neutrophils by partially purified Pasteurella haemolytica leukotoxin.
Infect. Immun.
59:3126-3133 |
| 10. | Dallegri, F., and L. Ottonello. 1997. Tissue injury in neutrophilic inflammation. Inflamm. Res. 46:382-391[CrossRef][Medline]. |
| 11. |
Ding, Z. M.,
J. E. Babensee,
S. I. Simon,
H. Lu,
J. L. Perrard,
D. C. Bullard,
X. Y. Dail,
S. K. Bromley,
M. L. Dustin,
M. L. Entman,
C. W. Smith, and C. M. Ballantyme.
1999.
Relative contribution of LFA-1 and Mac-1 to neutrophil adhesin and migration.
J. Immunol.
163:5029-5038 |
| 12. |
Henricks, P. A. J.,
G. J. Binkhorst,
A. A. Drijver, and F. P. Nijkamp.
1992.
Pasteurella haemolytica leukotoxin enhances production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by bovine polymorphonuclear leukocytes.
Infect. Immun.
60:3238-3243 |
| 13. | Himmel, M. E., M. D. Yates, L. H. Lauerman, and P. G. Squire. 1981. Purification and partial characterization of a macrophage cytotoxin from Pasteurella haemolytica. Am. J. Vet. Res. 43:764-767. |
| 14. |
Jeyaseelan, S.,
S. L. Hsuan,
M. S. Kannan,
B. K. Walcheck,
J. F. Wang,
M. E. Kehrli, Jr.,
E. T. Lally,
G. C. Sieck, and S. Maheswaran.
2000.
Lymphocyte function-associated antigen 1 is a receptor for Pasteurella haemolytica leukotoxin in bovine leukocytes.
Infect. Immun.
68:72-74 |
| 15. | Kishimoto, T. K., and D. C. Anderson. 1992. The role of integrins in inflammation, p. 353-406. In J. I. Galin, I. M. Golstein, and R. Snyderman (ed.), Inflammation: basic principles and clinical correlates. Raven Press, New York, N.Y. |
| 16. |
Lally, E. T.,
I. R. Kieba,
A. Sato,
C. L. Green,
J. Rosenbloom,
J. Korostoff,
J. F. Wang,
B. J. Shenker,
S. Ortlepp,
M. K. Robinson, and P. C. Billings.
1997.
RTX toxins recognize a B2 integrin on the surface of human target cells.
J. Biol. Chem.
272:30463-30469 |
| 17. | Leite, F., C. Malazdrewich, H. S. Yoo, S. K. Maheswaran, and C. J. Czuprynski. 1999. Use of TUNEL staining to detect apoptotic cells in the lungs of cattle experimentally infected with Pasteurella haemolytica. Microb. Pathog. 27:179-185[CrossRef][Medline]. |
| 18. | Li, J., K. D. Clinkenbeard, and J. W. Ritchey. 1999. Bovine CD18 identified as a species specific receptor for Pasteurella haemolytica leukotoxin. Vet. Microbiol. 2:91-97. |
| 19. | Maheswaran, S. K., D. J. Weiss, M. S. Kannan, E. L. Townsend, K. R. Reddy, L. O. Whiteley, and S. Srikumaran. 1992. Effects of Pasteurella haemolytica A1 leukotoxin on bovine neutrophils: degranulation and generation of oxygen-derived free radicals. Vet. Immunol. Immunopathol. 33:51-68[CrossRef][Medline]. |
| 20. |
Marcinkiewicz, C.,
S. Vijay-Kumar,
M. A. Mclane, and S. Niewiarowski.
1997.
Significance of the RDG loop and C-terminal domain of echistatin for recognition of alphaIIb beta3 integrin and expression of ligand-induced binding site.
Blood
90:1565-1575 |
| 21. | Morsey, M. A., A. G. Van-Kessel, Y. Popowych, D. Gordon, M. Campos, and L. A. Babiuk. 1999. Cytokine profiles following interaction between bovine alveolar macrophages and Pasteurella haemolytica. Microb. Pathog. 26:325-331[CrossRef][Medline]. |
| 22. | Ohmann, J. B., L. A. Babiuk, and R. Harland. 1991. Cytokine synergy with viral cytopathic effects and bacterial products during the pathogenesis of respiratory tract infection. Clin. Immunol. Immunopathol. 60:152-170[CrossRef]. |
| 23. | Ortiz-Carranza, O., and C. J. Czuprynski. 1992. Activation of bovine neutrophils by Pasteurella haemolytica leukotoxin is calcium dependent. J. Leukoc. Biol. 52:558-564[Abstract]. |
| 24. | Pardi, R. 1994. Inside-out and outside-in mechanisms in leukocyte adhesion. Fund. Clin. Immunol. 2:135-146. |
| 25. | Rehmtulla, A. J., and R. G. Thomson. 1981. A review of the lesions in shipping fever of cattle. Can. Vet. J. 22:1-8[Medline]. |
| 26. | Sample, A. K., and C. J. Czuprynski. 1991. Primary and stimulation of bovine neutrophils by recombinant human interleukin-1 alpha and tumor necrosis factor alpha. J. Leukoc. Biol. 49:107-115[Abstract]. |
| 27. |
Shewen, P. E., and B. N. Wilkie.
1982.
Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes.
Infect. Immun.
35:91-94 |
| 28. | Shewen, P. E., and B. N. Wilkie. 1985. Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria. Am. J. Vet. Res. 46:1212-1214[Medline]. |
| 29. | Shi, J., R. D. Goodbaud, M. M. Chegappa, J. L. Nelson, M. D. Tokach, D. S. McVey, and F. Blecha. 1994. Influence of interleukin-1 on neutrophil function and resistance to Streptococcus suis in neonatal pigs. J. Leukoc. Biol. 56:88-94[Abstract]. |
| 30. | Slocombe, R. F., J. Malark, R. T. Ingensoll, F. J. Derksen, and N. E. Robinson. 1985. Importance of neutrophils in the pathogenesis of acute pneumonic pasteurellosis in calves. Am. J. Vet. Res. 46:2253-2258[Medline]. |
| 31. | Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425-434[CrossRef][Medline]. |
| 32. | Stevens, P. K., and C. J. Czuprynski. 1995. Dissociation of cytolysis and monokine release by bovine mononuclear phagocytes incubated with Pasteurella haemolytica partially-purified leukotoxin and lipopolysaccharide. Can. J. Vet. Res. 59:110-117[Medline]. |
| 33. | Stevens, P. K., and C. J. Czuprynski. 1996. Pasteurella haemolytica leukotoxin induces bovine leukocytes to undergo morphologic changes consistent with apoptosis in vitro. Infect. Immun. 64:2687-2694[Abstract]. |
| 34. |
Sun, Y.,
K. D. Clinkenbeard,
L. A. Cudd,
C. R. Clarke, and P. A. Clinkenbeard.
1999.
Correlation of Pasteurella haemolytica leukotoxin binding with susceptibility to intoxication of lymphoid cells from various species.
Infect. Immun.
67:6264-6269 |
| 35. |
Walzog, B.,
F. Jeblonski,
A. Zakrzewicz, and P. Gaehtgens.
1999.
2 integrins (CD11/CD18) promote apoptosis of human neutrophils.
FASEB J.
11:1177-1186[Abstract].
|
| 36. | Wang, J. F., I. R. Kieba, J. Korostoff, T. L. Guo, N. Yamaguchi, H. Rozmiarek, P. C. Billings, B. J. Shenker, and E. T. Lally. 1998. Molecular and biochemical mechanisms of Pasteurella haemolytica leukotoxin-induced cell death. Microb. Pathog. 25:317-331[CrossRef][Medline]. |
| 37. | Welch, R. A. 1991. Pore-forming cytolysis of gram-negative bacteria. Mol. Microbiol. 5:521-528[Medline]. |
| 38. | Williams, M. A., and J. S. Solomkin. 1999. Integrin-mediated signaling in human neutrophil functioning. J. Leukoc. Biol. 65:725-735[Abstract]. |
| 39. | Wittum, T. E., N. E. Woollen, L. J. Perino, and E. T. Littledike. 1996. Relationship among treatment for respiratory tract disease, pulmonary lesions evident at slaughter and rate of weight gain in feedlot cattle. J. Am. Vet. Med. Assoc. 209:814-818[Medline]. |
| 40. | Yoo, H. S., B. S. Rajagopal, S. K. Maheswaran, and T. R. Ames. 1995. Purified Pasteurella haemolytica leukotoxin induces expression of inflammatory cytokines from bovine alveolar macrophages. Microb. Pathog. 18:237-252[CrossRef][Medline]. |
| 41. |
Yoo, H. S.,
S. K. Maheswaran,
S. Srinand,
T. R. Ames, and M. Suresh.
1995.
Increased tumor necrosis factor- and interleukin- 1 expression in the lungs of calves with experimental pneumonic pasteurellosis.
Vet. Immunol. Imunopathol.
49:15-28[CrossRef][Medline].
|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|